🩸Facts about Acute Hepatic Porphyria:
EPP1 and XLEPP genetics, afamelanotide’s mechanism of action, improved light tolerance, and treatment limitations in children.
#EPP #XLEPP #Porphyria #Afamelanotide #MC1R #Hematology #HemeOnc #MedEd #HemeHub
🩸Facts about Acute Hepatic Porphyria: EPP1 and XLEPP genetics, afamelanotide’s mechanism of action, improved light tolerance, and treatment limitations in children. #EPP #XLEPP #Porphyria #Afamelanotide #MC1R #Hematology #HemeOnc #MedEd #HemeHub
0 vue
Publié le 30/10/2026 17:09
0:29
🩸Facts about Acute Hepatic Porphyria:
EPP1 and XLEPP genetics, afamelanotide’s mechanism of action, improved light tolerance, and treatment limitations in children.
#EPP #XLEPP #Porphyria #Afamelanotide #MC1R #Hematology #HemeOnc #MedEd #HemeHub
0 commentaire
?